Prostate Cancer Trial, Recruiting (NCT05225428)

Prostate Cancer Trial, Recruiting NCT05225428 Sponsor: Dana-Farber Cancer Institute Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05225428 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
You have been diagnosed with, or previously had, breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, kidney cancer, melanoma, or sarcoma
You are able to understand spoken or written English or Spanish in a healthcare setting
You are willing and able to read and sign a consent form agreeing to take part in the study
You identify as Black or Latinx (this requirement applies to one specific part of the study only — confirm with trial site)

Who may not be able to join:

You have previously had genetic testing related to cancer
You have previously had genetic testing that looks at inherited genes passed down through families (confirm with trial site)
You currently have an active blood cancer, such as a type called chronic lymphocytic leukemia
You are currently pregnant
You are currently in prison or another form of incarceration

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Huma Q. Rana, MD., MPH, Dana-Farber Cancer Institute

Phone: 617) 632-6292

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05225428

Sponsor: Dana-Farber Cancer Institute

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 617) 632-6292

More information: https://clinicaltrials.gov/study/NCT05225428

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
You have been diagnosed with, or previously had, breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, kidney cancer, melanoma, or sarcoma
You are able to understand spoken or written English or Spanish in a healthcare setting
You are willing and able to read and sign a consent form agreeing to take part in the study
You identify as Black or Latinx (this requirement applies to one specific part of the study only — confirm with trial site)

Who may not be able to join:

You have previously had genetic testing related to cancer
You have previously had genetic testing that looks at inherited genes passed down through families (confirm with trial site)
You currently have an active blood cancer, such as a type called chronic lymphocytic leukemia
You are currently pregnant
You are currently in prison or another form of incarceration

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Dana-Farber Cancer Institute

Registry

ClinicalTrials.gov

Start date

4 August 2022

Est. completion

30 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Video Education Acceptability (Qualitative Interview Study)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov